Back
AstraZeneca PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
36
AZNCF
AstraZeneca PLC
Last Price:
125.46
Seasonality Move:
0.83%
Sell
4
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.60
Seasonality Move:
50.57%
Sell
36
AstraZeneca PLC (AZNCF)
is a Sell
Is AstraZeneca PLC a Buy, Sell or Hold?
- The current AstraZeneca PLC [AZNCF] share price is $127.96. The Score for AZNCF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- AZNCF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
4
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.59. The Score for ADAP is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
AZNCF Stock Price Chart
What is AstraZeneca PLC's stock price today?
-
The AstraZeneca PLC share price today is $127.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AZNCF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
AZNCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.89 | Sell |
| Relative Strength Index (14 RSI): | 29.35 | Sell |
| Chaikin Money Flow: | 1599 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (131.04 - 153.2) | Sell |
| Bollinger Bands (100): | (144.01 - 166.11) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 26.27 | Sell |
| Chaikin Money Flow: | -2051103 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 0.86) | Sell |
| Bollinger Bands (100): | (0.83 - 1.21) | Sell |
AZNCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 127.93 | Buy |
| 20-day SMA: | 139.65 | Sell |
| 50-day SMA: | 148.98 | Sell |
| 200-day SMA: | 148.22 | Sell |
| 8-day EMA: | 130.34 | Sell |
| 20-day EMA: | 137.01 | Sell |
| 50-day EMA: | 146.09 | Sell |
| 200-day EMA: | 148.44 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Sell |
| 20-day SMA: | 0.76 | Sell |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.71 | Sell |
| 20-day EMA: | 0.77 | Sell |
| 50-day EMA: | 0.87 | Sell |
| 200-day EMA: | 1.01 | Sell |
AstraZeneca PLC Earnings Growth & AZNCF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.11 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $0.33 per share.
AstraZeneca PLC Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||